Search: 
You do not have permission to access this chart.
Please Sign Up or Login
News for Virios Therapeutics, LLC (VIRI)
Newly released Crypto mining rig for Virios Therapeutics, LLC coins
minutes ago | Banggood.com
Everything Crypto on sale now!
58 minutes ago | Aliexpress.com
Virios Therapeutics Announces Second Quarter 2021 Financial Results and Provides Corporate Update
3 days ago | Business Wire
Virios Therapeutics to Present at the SNN Network Summer Virtual Conference
4 days ago | Business Wire
Virios Therapeutics Featured in Bloomberg TV Interview
6 days ago | Business Wire
Virios Therapeutics to Report Second Quarter 2021 Financial Results and Provide Corporate Update on Thursday, August 12, 2021
a week ago | Business Wire
VIRI Stock Increases Over 6% Pre-Market: Why It Happened
2 weeks ago | Pulse2
Virios Therapeutics Highlights Clinical Sites Fully Operational in Phase 2b Fibromyalgia Study Featuring FDA “Fast Track” Review Designated Antiviral Therapy, Oral IMC-1
2 weeks ago | Business Wire
Virios Therapeutics Stock Moves Higher On Promising IMC-1 Safety Data In Mid-Stage Fibromyalgia Trial
2 months ago | Benzinga
Virios Therapeutics Highlights Safety Data from Phase 2a Fibromyalgia Trial at the International Association for the Study of Pain (IASP) World Congress
2 months ago | Business Wire
Virios Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating IMC-1 in Patients with Fibromyalgia
2 months ago | Business Wire
Virios Therapeutics Presents Phase 2a Fibromyalgia Trial Data on Efficacy Analyses of Key Secondary Endpoints at the EULAR European Congress of Rheumatology
2 months ago | Business Wire

About:

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Its lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was incorporated in 2012 and is headquartered in Alpharetta, Georgia.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

3

Address:

Virios Therapeutics, LLC 44 Milton Avenue Alpharetta GA 30009 United States

Website:

http://www.virios.com

Phone:

866-620-8655

Leave a comment

Your email address will not be published. Required fields are marked *